Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Trellis Bioscience Inc. logo — Our human mAb TRL1068 disrupts bacterial biofilm and makes t...

Trellis Bioscience Inc.

Our human mAb TRL1068 disrupts bacterial biofilm and makes traditional antibiotics work again overcoming drug resistance

Founded 1998 United States Redwood City, United States 18 employees Grant Total: $28.58M Biotechnology, Health Care +1

General Information

Company Name Trellis Bioscience Inc.
Founded Year 1998
Location United States Redwood City, United States +1
Employees 18
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Grant
Social

Get notified when Trellis Bioscience Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Trellis Bioscience Inc.

Trellis Bioscience is a biotechnology startup pioneering cellular informatics to enhance and quantify therapeutic antibody treatments on a single cell level. The company, founded in 1998, offers a technology platform focused on cellular informatics, with a cell biology platform that provides a direct readout at the single cell level. This platform is pivotal in the discovery and production of therapeutic monoclonal antibodies. Trellis Bioscience's innovative technology allows for monitoring the activity of diverse cell types and quantifying the impact of potential therapeutic interventions. Based in San Francisco, California, the company received a $3.20M grant investment on 01 October 2019 from CARB-X. With its focus on precision medicine and cutting-edge technology, Trellis Bioscience is positioned to make significant contributions to the biotechnology and healthcare industries. This recent investment is a testament to the potential and value of the company's unique approach to cellular informatics.

Taxonomy: cellular informatics, therapeutic antibody treatments, technology platform, monoclonal antibodies, cell biology platform, single cell level, cell types monitoring, therapeutic interventions, San Francisco, discovery platform

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
01 Oct 2019
Debt Financing •••••• - 09 Nov 2011
Venture Round •••••• - 07 Aug 2009
Series B •••••• 4
Investor Investor Investor Investor
14 Feb 2007
Series A •••••• - 02 Jan 2004

Trellis Bioscience Inc. Alternatives & Competitors

Trellis Bioscience Inc. vs
Pure MHC, LLC
Pure MHC, LLC United States

Our Mission is to create a novel class of therapeutics for the treatment of cancer and infectious di...

5 employees
Biotechnology
Trellis Bioscience Inc. vs
Kling Biotherapeutics
Kling Biotherapeutics The Netherlands

Amsterdam based biotech developing novel antibody based therapeutics

Unknown
16 employees
Biopharma, Biotechnology
Trellis Bioscience Inc. vs
RevOpsis Therapeutics
RevOpsis Therapeutics

Harnessing a new era of multispecific biologics to discover ​ and develop breakthrough treatments

Seed
5 employees
Health Care, Life Sciences

FAQ About Trellis Bioscience Inc.

Our human mAb TRL1068 disrupts bacterial biofilm and makes traditional antibiotics work again overcoming drug resistance
Trellis Bioscience Inc. was founded in 1998.
Trellis Bioscience Inc. is headquartered in Redwood City, United States.
Trellis Bioscience Inc. operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Trellis Bioscience Inc. has approximately 18 employees.
Trellis Bioscience Inc. has completed 5 funding rounds, raising a total of $28.58M. The latest funding stage is Grant.
Top alternatives and competitors to Trellis Bioscience Inc. include Pure MHC, LLC, Kling Biotherapeutics, RevOpsis Therapeutics, Design Pharmaceuticals Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Trellis Bioscience Inc. and Pure MHC, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Trellis Bioscience Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy